Vis enkel innførsel

dc.contributor.authorKleive, Dyre
dc.contributor.authorAas, Eline
dc.contributor.authorAngelsen, Jon-Helge
dc.contributor.authorBringeland, Erling Audun
dc.contributor.authorNesbakken, Arild
dc.contributor.authorNymo, Linn Såve
dc.contributor.authorSchultz, Johannes Kurt
dc.contributor.authorSøreide, Kjetil
dc.contributor.authorYaqub, Sheraz
dc.date.accessioned2021-11-26T13:24:36Z
dc.date.available2021-11-26T13:24:36Z
dc.date.created2021-11-19T11:18:35Z
dc.date.issued2021
dc.identifier.issn2366-1070
dc.identifier.urihttps://hdl.handle.net/11250/2831707
dc.description.abstractThe timing of surgical resection of synchronous liver metastases from colorectal cancer has been debated for decades. Several strategies have been proposed, but high-level evidence remains scarce. Simultaneous resection of the primary tumour and liver metastases has been described in numerous retrospective audits and meta-analyses. The potential benefits of simultaneous resections are the eradication of the tumour burden in one procedure, overall shorter procedure time, reduced hospital stay with the likely benefits on quality of life and an expected reduction in the use of health care services compared to staged procedures. However, concerns about accumulating complications and oncological outcomes remain and the optimal selection criteria for whom simultaneous resections are beneficial remains undetermined. Based on the current level of evidence, simultaneous resection should be restricted to patients with a limited liver tumour burden. More high-level evidence studies are needed to evaluate the quality of life, complication burden, oncological outcomes, as well as overall health care implications for simultaneous resections.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleSimultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gapsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 the authorsen_US
dc.source.articlenumber111–120en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1007/s40487-021-00148-2
dc.identifier.cristin1956365
dc.source.journalOncology and Therapyen_US
dc.identifier.citationOncology and Therapy. 2021, 9, 111–120.en_US
dc.source.volume9en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal